Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Determining the Mutation Bias of Favipiravir in Influenza Virus Using Next-Generation Sequencing
Authors
Keywords
-
Journal
JOURNAL OF VIROLOGY
Volume 93, Issue 2, Pages -
Publisher
American Society for Microbiology
Online
2018-10-29
DOI
10.1128/jvi.01217-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Antiviral efficacy of favipiravir against Ebola virus: A translational study in cynomolgus macaques
- (2018) Jérémie Guedj et al. PLOS MEDICINE
- Influenza A virus hemagglutinin glycosylation compensates for antibody escape fitness costs
- (2018) Ivan Kosik et al. PLoS Pathogens
- Influenza antivirals currently in late-phase clinical trial
- (2017) Paulina Koszalka et al. Influenza and Other Respiratory Viruses
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Biochemical characterization of recombinant influenza A polymerase heterotrimer complex: Polymerase activity and mechanisms of action of nucleotide analogs
- (2017) Ona Barauskas et al. PLoS One
- Distinct Effects of T-705 (Favipiravir) and Ribavirin on Influenza Virus Replication and Viral RNA Synthesis
- (2016) Evelien Vanderlinden et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Approved Antiviral Drugs over the Past 50 Years
- (2016) Erik De Clercq et al. CLINICAL MICROBIOLOGY REVIEWS
- Species difference in ANP32A underlies influenza A virus polymerase host restriction
- (2016) Jason S. Long et al. NATURE
- Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin
- (2016) Michael Doud et al. Viruses-Basel
- Combinations of Oseltamivir and T-705 Extend the Treatment Window for Highly Pathogenic Influenza A(H5N1) Virus Infection in Mice
- (2016) Bindumadhav M. Marathe et al. Scientific Reports
- The Mutational Robustness of Influenza A Virus
- (2016) Elisa Visher et al. PLoS Pathogens
- Efficacy of T-705 (Favipiravir) in the Treatment of Infections with Lethal Severe Fever with Thrombocytopenia Syndrome Virus
- (2016) Hideki Tani et al. mSphere
- Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
- (2016) Ana I. de Ávila et al. PLoS One
- Efficacy of Favipiravir Alone and in Combination With Ribavirin in a Lethal, Immunocompetent Mouse Model of Lassa Fever
- (2015) Lisa Oestereich et al. JOURNAL OF INFECTIOUS DISEASES
- Effective Lethal Mutagenesis of Influenza Virus by Three Nucleoside Analogs
- (2015) Matthew D. Pauly et al. JOURNAL OF VIROLOGY
- Primer ID Validates Template Sampling Depth and Greatly Reduces the Error Rate of Next-Generation Sequencing of HIV-1 Genomic RNA Populations
- (2015) Shuntai Zhou et al. JOURNAL OF VIROLOGY
- The broad-spectrum antiviral favipiravir protects guinea pigs from lethal Lassa virus infection post-disease onset
- (2015) David Safronetz et al. Scientific Reports
- Successful treatment of advanced Ebola virus infection with T-705 (favipiravir) in a small animal model
- (2014) Lisa Oestereich et al. ANTIVIRAL RESEARCH
- Mutations in the chikungunya virus non-structural proteins cause resistance to favipiravir (T-705), a broad-spectrum antiviral
- (2014) Leen Delang et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- High-throughput profiling of influenza A virus hemagglutinin gene at single-nucleotide resolution
- (2014) Nicholas C. Wu et al. Scientific Reports
- The epidemiology and spread of drug resistant human influenza viruses
- (2014) Aeron C Hurt Current Opinion in Virology
- Favipiravir elicits antiviral mutagenesis during virus replication in vivo
- (2014) Armando Arias et al. eLife
- Mechanism of Action of T-705 Ribosyl Triphosphate against Influenza Virus RNA Polymerase
- (2013) Hidehiro Sangawa et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- T-705 (Favipiravir) Induces Lethal Mutagenesis in Influenza A H1N1 Viruses In Vitro
- (2013) T. Baranovich et al. JOURNAL OF VIROLOGY
- Characterization of H7N9 influenza A viruses isolated from humans
- (2013) Tokiko Watanabe et al. NATURE
- Viral population analysis and minority-variant detection using short read next-generation sequencing
- (2013) S. J. Watson et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
- (2013) Zhinan Jin et al. PLoS One
- Infectivity, Transmission, and Pathology of Human-Isolated H7N9 Influenza Virus in Ferrets and Pigs
- (2013) H. Zhu et al. SCIENCE
- Degenerate Primer IDs and the Birthday Problem
- (2012) D. J. Sheward et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Accurate sampling and deep sequencing of the HIV-1 protease gene using a Primer ID
- (2011) C. B. Jabara et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever
- (2011) Michelle Mendenhall et al. PLoS Neglected Tropical Diseases
- T-705 (Favipiravir) Inhibition of Arenavirus Replication in Cell Culture
- (2010) Michelle Mendenhall et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- In Vitro Antiviral Activity of Favipiravir (T-705) against Drug-Resistant Influenza and 2009 A(H1N1) Viruses
- (2010) K. Sleeman et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
- (2009) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Single-Reaction Genomic Amplification Accelerates Sequencing and Vaccine Production for Classical and Swine Origin Human Influenza A Viruses
- (2009) B. Zhou et al. JOURNAL OF VIROLOGY
- Global Transmission of Oseltamivir-Resistant Influenza
- (2009) Anne Moscona NEW ENGLAND JOURNAL OF MEDICINE
- T-705 (favipiravir) activity against lethal H5N1 influenza A viruses
- (2009) M. Kiso et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started